St. Vincent’s Riverside First in the Region to Offer Patients a Subcutaneous Implantable Defibrillator
St. Vincent’s Medical Center Riverside is the first hospital in the region to offer the S-ICD® System, an implantable defibrillator that sits just under the skin, leaving the heart muscle untouched. The device is designed for patients at risk of sudden cardiac arrest (SCA), an abrupt loss of heart function caused by chaotic activity of the heart.
“Sudden Cardiac Arrest can be frightening and life-threatening for patients who go unprotected,” said Cardiologist Dr. Jay Patterson, MD, St. Vincent’s Cardiology. “We are thrilled to offer patients in Northeast Florida and Southeast Georgia this new and improved life-saving technology.”
The S-ICD System constantly monitors a patient’s heart, delivering life-saving therapy if sudden cardiac arrest strikes. What makes the S-ICD System different from other implantable cardiac defibrillators is that it sits just under the skin without the need for thin, insulated wires – known as leads – to be placed into the heart itself. This leaves the heart and blood vessels untouched, providing many benefits for patients. Those include less scarring, less chance of infection and a quicker recovery.
“We are proud to offer this advanced therapy to help improve the quality of life for our patients,” said Cardiologist Dr. Timothy Walsh, MD, St. Vincent’s Cardiology. “St. Vincent’s has always been considered a leader in cardiac care and offering this technology reaffirms our commitment to patients.”
Recent estimates show approximately 850,000 people in the United States are at risk of SCA and need an ICD device, but remain unprotected.
St. Vincent’s performed its first S-ICD procedure in late January.